Specifically, miR-144 was down-regulated in colorectal cancer cells and tissues, and suppressed cancer development by directly targeting SMAD4 (Sheng et al., 2019) and CXCL11 (Han et al., 2018). The gene discussed is CXCL11; the disease is colorectal cancer.